Sugita Kazuya, Takata Noriyuki, Yonemochi Etsuo
Department of Physical Chemistry, Hoshi University, 2-4-41, Ebara, Shinagawa, Tokyo 142-8501, Japan.
Analytical Development Department, Chugai Pharmaceutical Co., Ltd., 5-5-1, Ukima, Kita, Tokyo 115-8543, Japan.
Pharmaceutics. 2022 Apr 7;14(4):816. doi: 10.3390/pharmaceutics14040816.
We evaluated the in vitro permeability of nanoparticle formulations of high and low lipophilic compounds under non-sink conditions, wherein compounds are not completely dissolved. The permeability of the highly lipophilic compound, griseofulvin, was improved by about 30% due to nanonization under non-sink conditions. Moreover, this permeability was about 50% higher than that under sink conditions. On the other hand, for the low lipophilic compound, hydrocortisone, there was no difference in permeability between micro-and nano-sized compounds under non-sink conditions. The nanonization of highly lipophilic compounds improves the permeability of the unstirred water layer (UWL), which in turn improves overall permeability. On the other hand, because the rate-limiting step in permeation for the low lipophilic compounds is the diffusion of the compounds in the membrane, the improvement of UWL permeability by nanonization does not improve the overall permeability. Based on this mechanism, nanoparticle formulations are not effective for low lipophilic compounds. To accurately predict the absorption of nanoparticle formulations, it is necessary to consider their permeability under non-sink conditions which reflect in vivo conditions.
我们评估了高亲脂性和低亲脂性化合物的纳米颗粒制剂在非漏槽条件下(即化合物未完全溶解)的体外渗透性。在非漏槽条件下,高亲脂性化合物灰黄霉素的渗透性因纳米化提高了约30%。此外,该渗透性比漏槽条件下高约50%。另一方面,对于低亲脂性化合物氢化可的松,在非漏槽条件下,微米级和纳米级化合物的渗透性没有差异。高亲脂性化合物的纳米化提高了未搅拌水层(UWL)的渗透性,进而提高了整体渗透性。另一方面,由于低亲脂性化合物渗透的限速步骤是化合物在膜中的扩散,纳米化对UWL渗透性的改善并未提高整体渗透性。基于这一机制,纳米颗粒制剂对低亲脂性化合物无效。为准确预测纳米颗粒制剂的吸收情况,有必要考虑其在反映体内情况的非漏槽条件下的渗透性。